REFRACTORY MALIGNANT SOLID NEOPLASM
Clinical trials for REFRACTORY MALIGNANT SOLID NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY MALIGNANT SOLID NEOPLASM trials appear
Sign up with your email to follow new studies for REFRACTORY MALIGNANT SOLID NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Targeted pill shows promise in slowing advanced cancers with specific gene flaws
Disease control CompletedThis study tested an oral drug called infigratinib in adults with advanced or metastatic solid tumors that have specific changes in FGFR genes. The goal was to see if blocking these overactive proteins could stop or slow tumor growth. Participants took the pill daily in repeating…
Matched conditions: REFRACTORY MALIGNANT SOLID NEOPLASM
Phase: PHASE2 • Sponsor: Sameek Roychowdhury • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Scientists test new drug duo in fight against tough cancers
Disease control CompletedThis early-stage study aimed to find the safest dose of two drugs, sapanisertib and ziv-aflibercept, when given together to patients with advanced solid tumors that had stopped responding to standard treatments. The main goal was to understand the side effects and determine the h…
Matched conditions: REFRACTORY MALIGNANT SOLID NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC